Alpha Teknova, Inc.

NASDAQ:TKNO

Drug Manufacturers - Specialty & Generic

Healthcare
$7.88 +4.55%

+$0.23 today

Market cap
$495.68M
Beta
0.63
P/E (TTM)
-16.2
EPS (TTM)
-$0.32
52W Low $1.91High $6.68

Volume 0.30M

Average 0.13M

TKNO Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Alpha Teknova, Inc.NASDAQ: TKNO

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares grows, but more slowly than its trailing trend

Q1 FY2026 weighted avg shares of 53.61M shares rose 0.3% year over year, behind the +11.4% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 0.1% from the prior quarter. Over 3 fiscal years it compounded at +24.0% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +0.3% toward the trailing-twelve-month pace of +11.4%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
53.61M+0.1% QoQ
Last fiscal yearDec 2025
53.48M+14.4% YoY
LTMMar 2026
53.53M+11.4% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+0.3%——
1 year+14.4%——
3-year CAGR+24.0%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
53.48M USD
Year-over-year change
+14.4%
4-year CAGR
+17.5%

Weighted Avg Shares vs competitors

How TKNO compares with its peers on the latest reported figures

  • TKNO's LTM Mar 2026 weighted avg shares of 53.53M shares is the 5th highest of the 8 companies compared; the peer median is 56.37M shares.
  • Its year-over-year change of +11.4% is the highest of 8, against a peer median of +1.8%.
  • Over three fiscal years its annual growth of +24.0% compares with a peer median of +1.2%.
TKNO Competitors Peer median
Weighted Avg Shares for TKNO and competitors
Company Period LTM YoY 3-year CAGR
LABStandard BioTools Inc.LTM Mar 2026384.09M +2.7%+69.5%
TECHBio-Techne CorporationLTM Sep 2026156.12M -0.3%-0.3%
MRVIMaravai LifeSciences Holdings, Inc.LTM Jun 2026146.04M +2.7%+3.3%
RGENRepligen CorporationLTM Jun 202656.37M +0.5%+0.5%
TKNOAlpha Teknova, Inc.LTM Mar 202653.53M +11.4%+24.0%
BLFSBioLife Solutions, Inc.LTM Mar 202647.98M +3.2%+4.0%
AZTAAzenta, Inc.LTM Sep 202645.14M -1.3%-12.0%
MLABMesa Laboratories, Inc.LTM Mar 20265.51M +1.8%+1.2%
Peer median (excluding TKNO) 56.37M+1.8%+1.2%

Competitors are the stored peer set for TKNO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue36.89M41.42M36.68M37.75M40.52M
Cost of Revenue19.27M23.94M26.39M30.51M27.08M
Gross Profit17.62M17.48M10.3M7.23M13.44M
Gross Margin47.8%42.2%28.1%19.2%33.2%
Research & Development4.31M7.74M5.57M2.76M2.2M
Selling, General & Admin24.17M37.45M34.78M29.47M27.07M
Operating Expenses29.63M67.14M45.86M33.38M30.42M
Depreciation & Amortization2.88M3.17M5.66M6.58M6.34M
EBITDA(9.17M)(25.69M)(25.54M)(19.57M)(10.15M)
EBITDA Margin-24.8%-62.0%-69.6%-51.8%-25.0%
Operating Income(12.01M)(49.66M)(35.56M)(26.15M)(16.98M)
Operating Margin-32.5%-119.9%-96.9%-69.3%-41.9%
Interest Income0213K000
Interest Expense589K0833K687K710K
Other Income / Expenses(629K)268K(1.52M)(687K)(225K)
Income Before Tax(12.64M)(49.39M)(37.08M)(26.83M)(17.2M)
Pre-Tax Margin-34.3%-119.2%-101.1%-71.1%-42.5%
Income Tax Expense(2.83M)(1.92M)(298K)(88K)58K
Net Income(9.8M)(47.47M)(36.78M)(26.75M)(17.26M)
Net Margin-26.6%-114.6%-100.3%-70.9%-42.6%
EPS (Basic)(0.35)(1.69)(1.16)(0.57)(0.32)
EPS (Diluted)(0.35)(1.69)(1.16)(0.57)(0.32)
Weighted Avg Shares28.01M28.08M31.82M46.75M53.48M
Weighted Avg Shares (Diluted)28.01M28.08M31.82M46.75M53.48M

Alpha Teknova, Inc.

NASDAQ:TKNO

Intrinsic Alpha fair value

Locked

Current Price

$7.88

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.